Academic
Publications
A phase I study of sirolimus and bevacizumab in patients with advanced malignancies

A phase I study of sirolimus and bevacizumab in patients with advanced malignancies,10.1016/j.ejca.2011.02.017,European Journal of Cancer,E. E. W. Coh

A phase I study of sirolimus and bevacizumab in patients with advanced malignancies  
BibTex | RIS | RefWorks Download
BackgroundWe performed a single institution, phase I study of sirolimus and bevacizumab, in order to determine the dose limiting toxicity (DLT) and recommended phase II doses.
Journal: European Journal of Cancer - EUR J CANCER , vol. 47, no. 10, pp. 1484-1489, 2011
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.